221 related articles for article (PubMed ID: 21082043)
1. Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2.
Rantala JK; Edgren H; Lehtinen L; Wolf M; Kleivi K; Vollan HK; Aaltola AR; Laasola P; Kilpinen S; Saviranta P; Iljin K; Kallioniemi O
Neoplasia; 2010 Nov; 12(11):877-88. PubMed ID: 21082043
[TBL] [Abstract][Full Text] [Related]
2. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
[TBL] [Abstract][Full Text] [Related]
3. GINS2 promotes cell proliferation and inhibits cell apoptosis in thyroid cancer by regulating CITED2 and LOXL2.
Ye Y; Song YN; He SF; Zhuang JH; Wang GY; Xia W
Cancer Gene Ther; 2019 Mar; 26(3-4):103-113. PubMed ID: 30177819
[TBL] [Abstract][Full Text] [Related]
4. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
[TBL] [Abstract][Full Text] [Related]
5. GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.
Peng L; Song Z; Chen D; Linghu R; Wang Y; Zhang X; Kou X; Yang J; Jiao S
Biomed Pharmacother; 2016 Dec; 84():1568-1574. PubMed ID: 27829549
[TBL] [Abstract][Full Text] [Related]
6. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.
Yu H; Jiang Y; Liu L; Shan W; Chu X; Yang Z; Yang ZQ
Oncotarget; 2017 Feb; 8(8):13099-13115. PubMed ID: 28055972
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy.
Bièche I; Vacher S; Lallemand F; Tozlu-Kara S; Bennani H; Beuzelin M; Driouch K; Rouleau E; Lerebours F; Ripoche H; Cizeron-Clairac G; Spyratos F; Lidereau R
Mol Cancer; 2011 Feb; 10():23. PubMed ID: 21352579
[TBL] [Abstract][Full Text] [Related]
8. An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.
Gatza ML; Silva GO; Parker JS; Fan C; Perou CM
Nat Genet; 2014 Oct; 46(10):1051-9. PubMed ID: 25151356
[TBL] [Abstract][Full Text] [Related]
9. GINS Complex Subunit 2 Facilitates Gastric Adenocarcinoma Proliferation and Indicates Poor Prognosis.
Feng H; Zeng J; Gao L; Zhou Z; Wang L
Tohoku J Exp Med; 2021 Oct; 255(2):111-121. PubMed ID: 34629365
[TBL] [Abstract][Full Text] [Related]
10. Roles of GINS2 in K562 human chronic myelogenous leukemia and NB4 acute promyelocytic leukemia cells.
Gao Y; Wang S; Liu B; Zhong L
Int J Mol Med; 2013 Jun; 31(6):1402-10. PubMed ID: 23589040
[TBL] [Abstract][Full Text] [Related]
11. An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.
Jiang Y; Liu L; Shan W; Yang ZQ
Mol Oncol; 2016 Feb; 10(2):292-302. PubMed ID: 26588862
[TBL] [Abstract][Full Text] [Related]
12. GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1.
Hu H; Ye L; Liu Z
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35137928
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer.
Chi F; Wang Z; Li Y; Chang N
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181475
[TBL] [Abstract][Full Text] [Related]
14. Effect of GINS2 on proliferation and apoptosis in leukemic cell line.
Zhang X; Zhong L; Liu BZ; Gao YJ; Gao YM; Hu XX
Int J Med Sci; 2013; 10(12):1795-804. PubMed ID: 24273454
[TBL] [Abstract][Full Text] [Related]
15. Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target.
Wu Q; Ding W; Mirza A; Van Arsdale T; Wei I; Bishop WR; Basso A; McClanahan T; Luo L; Kirschmeier P; Gustafson E; Hernandez M; Liu S
J Biol Chem; 2005 Apr; 280(13):12935-43. PubMed ID: 15659406
[TBL] [Abstract][Full Text] [Related]
16. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
[TBL] [Abstract][Full Text] [Related]
17. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
Meng W; Jiang Z; Zhang X; Cai B; Ma L; Guan Y
Comput Math Methods Med; 2022; 2022():3119721. PubMed ID: 36466552
[TBL] [Abstract][Full Text] [Related]
19. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
20. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
